Effects of blood pressure and lipid lowering on cognition
Jackie Bosch, Martin O’Donnell, Balakumar Swaminathan, Eva Lonn et autres
OBJECTIVE: To assess whether long-term treatment with candesartan/hydrochlorothiazide, rosuvastatin, or their combination can slow cognitive decline in older people at intermediate cardiovascular risk. METHODS: The Heart Outcomes Prevention Evaluation-3 (HOPE-3) study was a double-blind, randomized, placebo-controlled clinical trial using a 2 × …
ca (code pays fourni par la source)